Search results

Order by most recent / most popular / relevance

Results: 1-3 of 3

Medical treatment and diagnostic claims are patentable

Kilpatrick Townsend & Stockton LLP
-
USA
-
September 18 2009

The Federal Circuit has calmed some anxiety over the patentability of medical diagnostic methods under 35 U.S.C. 101 with its decision in Prometheus Laboratories, Inc. v. Mayo Collaborative Services, holding that some method of treatment and diagnostic methods are indeed patentable subject matter

In re Kubin another hurdle for DNA sequence patents

Kilpatrick Townsend & Stockton LLP
-
USA
-
April 7 2009

A typical scenario in the development of biotech patents claiming DNA sequences: a bench researcher discovers the isolation and characterization of a protein that may have desirable biological activity and publishes a paper describing the results

Separate written description? Oral arguments in en banc rehearing of Ariad v. Lilly

Kilpatrick Townsend & Stockton LLP
-
USA
-
December 8 2009

The U.S. Court of Appeals for the Federal Circuit heard oral arguments on December 7 in its en banc rehearing of Ariad Pharmaceuticals Inc. v. Eli Lilly & Co., Fed. Cir., No. 2008-1248

Search results

Medical treatment and diagnostic claims are patentable

In re Kubin another hurdle for DNA sequence patents

Separate written description? Oral arguments in en banc rehearing of Ariad v. Lilly

Current Search

Suggested Facets

Author

Workarea